original ) (raw )Increased arachidonic acid uptake by platelets from insulin-dependent diabetics and diabetic rats
Jose Enrique
Diabetes Research and Clinical Practice, 1989
View PDFchevron_right
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients
Bente Halvorsen
Free Radical Biology and Medicine, 2012
View PDFchevron_right
The potential benefit of omega-3 fatty acid capsule on Mean platelet volume and Platelet count in type-2 Diabetes Mellitu
Qazi Shamima Akhter
2020
View PDFchevron_right
Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM)
sanjay srivastava
Thrombosis Research, 1994
View PDFchevron_right
In Vitro Glycoxidized Low-Density Lipoproteins and Low-Density Lipoproteins Isolated from Type 2 Diabetic Patients Activate Platelets via p38 Mitogen-Activated Protein Kinase
Michel Lagarde
The Journal of Clinical Endocrinology & Metabolism, 2007
View PDFchevron_right
Diabetic Patients Without Vascular Complications Display Enhanced Basal Platelet Activation and Decreased Antioxidant Status
Michel Lagarde
Diabetes, 2004
View PDFchevron_right
Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function
Michel Lagarde
Progress in Lipid Research, 1988
View PDFchevron_right
Diacylglycerol lipase pathway is a minor source of released arachidonic acid in thrombin-stimulated human platelets
Bruce Holub
Biochemical and Biophysical Research Communications, 1986
View PDFchevron_right
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients
Michel Lagarde
Thrombosis and haemostasis, 2015
View PDFchevron_right
In Vivo Formation of 8-Iso-Prostaglandin F2 and Platelet Activation in Diabetes Mellitus : Effects of Improved Metabolic Control and Vitamin E Supplementation
Tonino Bucciarelli
Circulation, 1999
View PDFchevron_right
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Maria Febbraio
Nature Medicine, 2007
View PDFchevron_right
Differential Alterations of Spontaneous and Stimulated 45Ca2+ Uptake by Platelets from Patients with Type I and Type II Diabetes Mellitus
Paresh Dandona
Journal of Diabetes and its Complications, 1999
View PDFchevron_right
In Vivo Formation of 8-Iso-Prostaglandin F2a and Platelet Activation in Diabetes Mellitus Effects of Improved Metabolic Control and Vitamin E Supplementation
Elsa Pennese
View PDFchevron_right
Comparison of Platelet CD Markers between Normal Individuals and Untreated Patients with Type 2 Diabetes Mellitus
Muhammad Saboor
Journal of Hematology & Thromboembolic Diseases, 2013
View PDFchevron_right
In Vivo Formation of 8-Iso-Prostaglandin F 2α and Platelet Activation in Diabetes Mellitus
Elsa Pennese
Circulation, 1999
View PDFchevron_right
Platelet activation in type 2 diabetes mellitus
Stefania Basili
Journal of Thrombosis and Haemostasis, 2004
View PDFchevron_right
Effects of alimentary lipemia and inflammation on platelet CD40-ligand
xuan duc nguyen
Thrombosis Research, 2007
View PDFchevron_right
Dietary n-9, n-6 and n-3 fatty acids modify linoleic acid more than arachidonic acid levels in plasma and platelet lipids and minimally affect platelet thromboxane formation in the rabbit
Susanna Colli
The Journal of Nutritional Biochemistry, 1990
View PDFchevron_right
Platelet Activation and Platelet–Leukocyte Aggregates in Type I Diabetes Mellitus
Ismail Mohamad
Clinical and Applied Thrombosis/Hemostasis
View PDFchevron_right
Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects
Satu Vehkavaara
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 2003
View PDFchevron_right
Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes
Salam Ibrahim
Atherosclerosis, 2009
View PDFchevron_right
Dietary arachidonic acid supplementation increases thromboxane synthesizing activity in platelets from diabetics
Masataka Shiraki
Prostaglandins, Leukotrienes and Medicine, 1983
View PDFchevron_right
The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus
Berta Soldevila
Journal of Clinical Medicine
View PDFchevron_right
Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes
Walter Krugluger
European Journal of Clinical Investigation, 2004
View PDFchevron_right
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis
Bianca Rocca
Cardiovascular Research, 2021
View PDFchevron_right
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets
Michel Lagarde
Diabetologia, 2011
View PDFchevron_right
Fatty acid-derived lipid mediators and blood platelet aggregation
Michel Guichardant
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2010
View PDFchevron_right
Arachidonic acid metabolism in platelets and endothelial cells
Babette Weksler
Progress in Lipid Research, 1981
View PDFchevron_right
Basal concentrations of free and esterified monohydroxylated fatty acids in human blood platelets
Michel Guichardant
Clinical chemistry, 1997
View PDFchevron_right